SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-017470
Filing Date
2022-11-10
Accepted
2022-11-10 17:16:52
Documents
55
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q capr-20220930x10q.htm   iXBRL 10-Q 1408175
2 EX-31.1 capr-20220930xex31d1.htm EX-31.1 9964
3 EX-31.2 capr-20220930xex31d2.htm EX-31.2 9826
4 EX-32.1 capr-20220930xex32d1.htm EX-32.1 5847
5 EX-32.2 capr-20220930xex32d2.htm EX-32.2 5808
  Complete submission text file 0001558370-22-017470.txt   5482648

Data Files

Seq Description Document Type Size
6 EX-101.SCH capr-20220930.xsd EX-101.SCH 43070
7 EX-101.CAL capr-20220930_cal.xml EX-101.CAL 40204
8 EX-101.DEF capr-20220930_def.xml EX-101.DEF 160119
9 EX-101.LAB capr-20220930_lab.xml EX-101.LAB 322691
10 EX-101.PRE capr-20220930_pre.xml EX-101.PRE 272706
49 EXTRACTED XBRL INSTANCE DOCUMENT capr-20220930x10q_htm.xml XML 826539
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34058 | Film No.: 221378598
SIC: 2834 Pharmaceutical Preparations